Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Cardiac Science, Inc. (NasdaqNM:DFIB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Recent Events
Aug 16Price hit new 52-week low ($1.81)
Aug 15Earnings Announcement
Location
16931 Millikan Avenue
Irvine, CA 92606
Phone: (949) 587-0357
Fax: (949) 951-7315
Email: investorinfo@cardiacscience.com
Employees (last reported count): 99
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 42%
·Over the last 6 months:
 · 8 insider buys; 43.0K shares (0.4% of insider shares)
·Institutional: 3% (5% of float)
(10 institutions)
·Net Inst. Buying: 45.0K shares (+6.36%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Cardiac Science, Inc. owns a technology platform that consists of proprietary arrhythmia detection and discrimination software and defibrillation hardware and electrode technology, which are combined to create a line of fully automatic external cardioverter defibrillator (AECD) devices. These AECDs are designed to be prophylactically attached to patients at temporary risk of sudden cardiac arrest, and will continuously monitor a patient's heart rhythms; instantly and accurately detect the onset of any life-threatening arrhythmias; and when appropriate and without the aid of hospital staff, automatically deliver potentially life saving defibrillation shocks within seconds to convert a patient's heart back to its normal rhythm. The Company's Powerheart is the only FDA cleared, fully automatic non-invasive external cardioverter defibrillator device. The Company is also currently developing two additional AECD products: Cardiac Rhythm Module and Personal Wearable Defibrillator.
More from Market Guide: Expanded Business Description

Financial Summary
Cardiac Science, Inc. develops automatic external cardioverter defibrillator devices, and manufactures and distributes cardiac devices and supplies. For the six months ended 6/30/01, revenues rose 45% to $2.2 million. Net loss rose from $5.5 million to $12.4 million. Revenues reflect higher sales of defibrillators, patient monitoring equipment and Powerheart units. Higher loss reflects an increase in R&D and S/G/A costs due to higher salaries and benefits expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Pay

Paul Quadros, 53
Chairman
--  
Raymond Cohen, 40
Pres, CEO
$236K
Roderick De Greef
CFO, Exec. VP
--  
Guy Sohie
Sr. VP, Operations
--  
Jeffery Blanton, 44
VP - Operations
130K
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:DFIBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 16-Aug-2001
$1.81 
Recent Price$2.20 
52-Week High
on 21-Sep-2000
$10.00 
Beta0.87 
Daily Volume (3-month avg)111.8K
Daily Volume (10-day avg)47.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-67.1%
52-Week Change
relative to S&P500
-55.9%
Share-Related Items
Market Capitalization$54.7M
Shares Outstanding24.9M
Float14.4M
Dividends & Splits
Annual Dividendnone 
Last Split: 2 for 23 on 8-Sep-1997
Per-Share Data
Book Value (mrq)$0.67 
Earnings (ttm)-$1.67 
Earnings (mrq)-$0.29 
Sales (ttm)$0.20 
Cash (mrq)$0.17 
Valuation Ratios
Price/Book (mrq)3.27 
Price/EarningsN/A 
Price/Sales (ttm)10.84 
Income Statements
Sales (ttm)$4.94M
EBITDA (ttm)-$36.6M
Income available to common (ttm)-$39.8M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-144.75%
Return on Equity (ttm)-177.92%
Financial Strength
Current Ratio (mrq)1.38 
Debt/Equity (mrq)0.02 
Total Cash (mrq)$4.12M
Short Interest
As of 8-Aug-2001
Shares Short37.0K
Percent of Float0.3%
Shares Short
(Prior Month)
37.0K
Short Ratio0.14 
Daily Volume259.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Some event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.